Rationale and design of the multicenter, national, randomized, open labeled phase III trial: allogeneic stem cell transplantation as a potential curative treatment for patients with relapsed or progressed multiple myeloma (AlloRelapseMM Study) - Glöckner, Annemarie; Schönland, Stefan; Einsele, Hermann; Kröger, Nicolaus (BMC cancer, 2025)
Gesehen am 06.08.2025